News | Magnetic Resonance Imaging (MRI) | May 02, 2017

Quality of MAGiC Brain Scans Non-Inferior to Conventional MRI

Study of multi-contrast MR technique finds synthetically-generated scans are of similar diagnostic quality to conventional scans

Quality of MAGiC Brain Scans Non-Inferior to Conventional MRI

May 2, 2017 — A new study published in the American Journal of Neuroradiology (AJNR) compares the MAGiC (Magnetic Resonance Image Compilation) software to conventional MRI. MAGiC is a customized version of SyntheticMR’s SyMRI IMAGE software marketed by GE Healthcare under a license agreement. Clinicians from six different sites compared the two methods and verified that the image quality of MAGiC is comparable to conventional images. 

The study, conducted by GE Healthcare and published in the American Journal of Neuroradiology (AJNR), comprised a set of 1,526 images that were read by seven neuroradiologists comparing synthetic and conventional MR brain images from 109 subjects with neuroimaging indications. The results revealed that the diagnostic quality of the images generated synthetically were non-inferior to conventional imaging.

MAGiC is the industry’s first multi-contrast MR technique cleared with the U.S. Food and Drug Administration (FDA), according to SyntheticMR. The technique gives clinicians more data than conventional scanning in a substantially shorter time frame. MAGiC gives users the flexibility to adjust the images retrospectively, leading to significant timesaving, fewer rescans and therefore cost savings, which combined, can assist the clinician in making a more decisive diagnosis.

For more information: www.gehealthcare.com

Related Content

Sponsored Content | Videos | Pediatric Imaging | February 22, 2018
FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite Inc., are offering a full-suite pediatric solutions...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
FDA Clears Siemens Healthineers' GOKnee3D MRI Application
Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018
The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
Sponsored Content | Videos | Artificial Intelligence | February 15, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Videos | Pediatric Imaging | February 14, 2018
ITN Associate Editor Jeff Zagoudis demonstrates several mobile apps designed to help pediatric patients learn what an
Overlay Init